Evidence map›Paper›PMID 29532409›Full record

ArticlePathology oncology research : POR2019

Protein Expression Analysis in Uterine Cervical Cancer for Potential Targets in Treatment.

Sugela Blancas, Rogelio Medina-Berlanga, Liliana Ortíz-García, Alfredo Loredo-Ramírez, Leticia Santos

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. SEL1L plays a major role in human malignant gliomas.The journal of pathology. Clinical research · 2020
    Article
  4. Proteomic Screening for Serum Biomarkers for Cervical Cancer and Their Clinical Significance.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sugela BlancasDivisión de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica, A.C. (IPICYT), San Luis Potosí, Mexico.
Rogelio Medina-BerlangaDivisión de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica, A.C. (IPICYT), San Luis Potosí, Mexico.
Liliana Ortíz-GarcíaFacultad de Ingeniería en Biotecnología, Universidad Politécnica de Pénjamo, Pénjamo, Guanajuato, Mexico.
Alfredo Loredo-RamírezLaboratorio de Patología Quirúrgica, Mariano Arista 743, Interior 208, San Luis Potosí, Mexico.
Leticia SantosDivisión de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica, A.C. (IPICYT), San Luis Potosí, Mexico. lsantos@ipicyt.edu.mx.ORCID http://orcid.org/0000-0002-7992-7487

Funding

CONACYT 2011-1-160607
6 · The paper itself

Abstract

Specific markers in lesions of the human uterine cervix cancer (UCC) are still needed for prognostic, diagnostic and/or therapeutic purposes. In this study we evaluated key molecules at protein level between normal epithelium, cervical intraepithelial neoplasia (CIN1-3) and invasive cancer of a group of molecules previously reported at mRNA level. For that purpose, human formalin-fixed paraffin embedded tissue microarrays (TMAs) were constructed containing 205 Mexican tissue core specimens. Immunohistochemistry and quantitative analysis of histological staining was performed against twenty-two distinct proteins for each core and the processing platform ImageJ. In the progression of the disease we found key statistical differences for the proteins SEL1, Notch3 and SOCS3. High expressions of SEL1L, Notch3 and SOCS3 have potential value to increase the prognostic of UCC in combination with markers such as p16

Indexed as

Biomarkers, TumorFemaleHumansProteinsReceptor, Notch3Suppressor of Cytokine Signaling 3 ProteinUterine Cervical DysplasiaUterine Cervical NeoplasmsBiomarkers, TumorNOTCH3 protein, humanProteinsReceptor, Notch3SEL1L protein, humanSOCS3 protein, humanSuppressor of Cytokine Signaling 3 ProteinImmunohistochemistryNotch3SEL1LSOCS3Tissue microarrayUterine cervical cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.